Elisabeth A. Sandoval Little's Insider Trades & SAST Disclosures
Elisabeth A. Sandoval Little's most recent trade in VYNE Therapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 12, 2024.
Add Superstar Alert
Note
This is a custom search result for pattern Elisabeth A. Sandoval Little.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
VYNE Therapeutics Inc
High Loss High Volume |
Elisabeth A. Sandoval Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
|
Procept BioRobotics Corp
|
Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,526 | 2,526 | - | - | Stock Option (Right to Buy) | |
|
Procept BioRobotics Corp
|
Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 1,376 | 11,023 | - | 0 | Common Stock | |
|
VYNE Therapeutics Inc
High Loss High Volume |
Sandoval-Little A. Elisabeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
|
VYNE Therapeutics Inc
High Loss High Volume |
A. Elisabeth Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
|
Procept BioRobotics Corp
|
Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 4,865 | 4,865 | - | - | Stock Option (Right to Buy) | |
|
Procept BioRobotics Corp
|
Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 2,711 | 9,647 | - | 0 | Common Stock | |
|
VYNE Therapeutics Inc
High Loss High Volume |
Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
|
Procept BioRobotics Corp
|
Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 4,205 | 4,205 | - | - | Common Stock | |
|
Procept BioRobotics Corp
|
Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 37.48 per share. | 07 Jun 2022 | 2,001 | 6,936 | - | 37.5 | 74,997 | Common Stock |
|
Procept BioRobotics Corp
|
A. Sandoval-Little Elisabeth | Director | Grant, award, or other acquisition of securities at price $ 40.46 per share. | 21 Oct 2021 | 4,935 | 4,935 | - | 40.5 | 199,670 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges